NutriBand (NTRB) Enterprise Value (2016 - 2026)
NutriBand (NTRB) posted Enterprise Value of -$4.0 million for Q2 2026, up 12.43% sequentially from -$4.6 million in Q1 2026, and down 35.16% YoY from -$6.2 million in Q2 2025.
NutriBand (NTRB) Enterprise Value (2016 - 2026) Analysis & Trends
NutriBand has reported Enterprise Value for 11 years, with the latest figure at -$4.0 million in Q2 2026.
- Quarterly Enterprise Value fell 35.16% year-over-year to -$4.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$4.0 million (down 35.16% YoY) and the FY2026 annual result came in at -$4.6 million, down 6.1% from the prior year.
- Enterprise Value improved to -$4.0 million in Q2 2026 per NTRB's latest filing, from -$4.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$492942.0 in Q1 2024 and troughed at -$8.3 million in Q2 2024.
- A 5-year average of -$4.0 million and a median of -$4.0 million in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value slumped 3118.48% in 2022, then surged 75.17% in 2024.
- Over 5 years, Enterprise Value stood at -$2.8 million in 2022, then jumped by 55.07% to -$1.3 million in 2023, then plunged by 350.33% to -$5.7 million in 2024, then climbed by 6.77% to -$5.3 million in 2025, then advanced by 24.58% to -$4.0 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$4.0 million, -$4.6 million, and -$5.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | NutriBand | 46.38 Mn | 42.37 Mn | 196,801.00 | -4.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -4.01 Mn |
| Jan 31, 2026 | -4.57 Mn |
| Oct 31, 2025 | -5.31 Mn |
| Jul 31, 2025 | -7.00 Mn |
| Apr 30, 2025 | -2.96 Mn |
| Jan 31, 2025 | -4.31 Mn |
| Oct 31, 2024 | -5.70 Mn |
| Jul 31, 2024 | -6.76 Mn |
| Apr 30, 2024 | -8.35 Mn |
| Jan 31, 2024 | -492,942.00 |
| Oct 31, 2023 | -1.27 Mn |
| Jul 31, 2023 | -2.33 Mn |
| Apr 30, 2023 | -1.28 Mn |
| Jan 31, 2023 | -1.99 Mn |
| Oct 31, 2022 | -2.82 Mn |
| Jul 31, 2022 | -3.34 Mn |
| Apr 30, 2022 | -4.01 Mn |
| Jan 31, 2022 | -4.89 Mn |
| Oct 31, 2021 | -5.49 Mn |
| Jul 31, 2021 | -304,258.00 |